Reaction equation
[NH2:1][N:2]1[CH2:6][CH2:5][O:4][C:3]1=[O:7].[F:8][C:9]1[CH:18]=[C:17]2[C:12]([CH:13]=[CH:14][CH:15]=[N:16]2)=[CH:11][C:10]=1[CH2:19][C:20]1[N:24]2[N:25]=[C:26]([C:29](=O)[CH3:30])[CH:27]=[CH:28][C:23]2=[N:22][CH:21]=1>>[F:8][C:9]1[CH:18]=[C:17]2[C:12]([CH:13]=[CH:14][CH:15]=[N:16]2)=[CH:11][C:10]=1[CH2:19][C:20]1[N:24]2[N:25]=[C:26](/[C:29](=[N:1]/[N:2]3[CH2:6][CH2:5][O:4][C:3]3=[O:7])/[CH3:30])[CH:27]=[CH:28][C:23]2=[N:22][CH:21]=1Participants
3
Procedure
The title compound was prepared from 3-aminooxazolidin-2-one and 1-[3-(7-fluoro-quinolin-6-ylmethyl)-imidazo[1,2-b]pyridazin-6-yl]-ethanone in analogy to the synthesis of example 1 in 24% yield. 1H-NMR (400 MHz, CDCl3) δ ppm 8.85 (dd, 1H), 8.02 (d, 1H), 7.88 (m, 2H), 7.71 (m, 3H), 7.33 (q, 1H), 4.58 (s, 2H), 4.51 (t, 2H), 4.01 (t, 2H), 2.49 (s, 3H). LCMS (method A): [MH]+=405, tR=4.76 min.
Sources & evidence
- ORD record
- ord-3b5abdacef854cb99d413e07199c062d
- Source dataset
- uspto-grants-2013_07
- Patent number
- US08497368B2
Linked notes
Loading…